HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel
TUCSON, Ariz. , July 28, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch and immediate availability of the HTG EdgeSeq Pan B-Cell Lymphoma Panel in the United States and
- Category:
- Press Releases